UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Scientific reports, 2024-01, Vol.14 (1), p.292-292, Article 292

2024

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Antibodies for Academia: A Practical Approach

Chimia, 2016-12, Vol.70 (12), p.893

2016

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Scientific reports, 2024-03, Vol.14 (1), p.7399-7399

2024

Link zum Volltext

Verfügbarkeit prüfen

Microbicides and other topical strategies to prevent vaginal transmission of HIV

Nature Reviews: Immunology, 2006-05, Vol.6 (5), p.371-382

2006

Link zum Volltext

Verfügbarkeit prüfen

Deciphering the code for retroviral integration target site selection

PLoS computational biology, 2010-11, Vol.6 (11), p.e1001008-e1001008

2010

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines

Proceedings of the National Academy of Sciences - PNAS, 2013-06, Vol.110 (23), p.9475-9480

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting Chemokine Receptors in HIV : A Status Report

Annual review of pharmacology and toxicology, 2008-01, Vol.48 (1), p.425-461

2008

Link zum Volltext

Verfügbarkeit prüfen

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Frontiers in immunology, 2023, Vol.14, p.1155200-1155200

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Science (American Association for the Advancement of Science), 2004-10, Vol.306 (5695), p.485-487

2004

Link zum Volltext

Verfügbarkeit prüfen

Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide

Proceedings of the National Academy of Sciences - PNAS, 2008-11, Vol.105 (46), p.17706-17711

2008

Link zum Volltext

Verfügbarkeit prüfen

Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5

PloS one, 2015-04, Vol.10 (4), p.e0125396-e0125396

2015

Link zum Volltext

Verfügbarkeit prüfen

Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants

Molecular therapy, 2016-09, Vol.24 (9), p.1675-1685

2016

Link zum Volltext

Verfügbarkeit prüfen

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

PloS one, 2015-07, Vol.10 (7), p.e0132780-e0132780

2015

Link zum Volltext

Verfügbarkeit prüfen

Alteration of synaptic network dynamics by the intellectual disability protein PAK3

The Journal of neuroscience, 2012-01, Vol.32 (2), p.519-527

2012

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

World journal of cardiology, 2014-05, Vol.6 (5), p.314-326

2014

Link zum Volltext

Verfügbarkeit prüfen

An engineered CX3CR1 antagonist endowed with anti-inflammatory activity

Journal of leukocyte biology, 2009-10, Vol.86 (4), p.903-911

2009

Link zum Volltext

Verfügbarkeit prüfen

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

Brain Research Reviews, 2005-02, Vol.48 (1), p.16-42

2005

Link zum Volltext

Verfügbarkeit prüfen

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

PloS one, 2011-07, Vol.6 (7), p.e22020-e22020

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1

Scientific reports, 2017-07, Vol.7 (1), p.4956-15, Article 4956

2017

Link zum Volltext

Verfügbarkeit prüfen

Medicinal Chemistry Applied to a Synthetic Protein: Development of Highly Potent HIV Entry Inhibitors

Proceedings of the National Academy of Sciences - PNAS, 2004-11, Vol.101 (47), p.16460-16465

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficient Orthogonal Bioconjugation of Dendrimers for Synthesis of Bioactive Nanoparticles

Bioconjugate chemistry, 2011-06, Vol.22 (6), p.1103-1114

2011

Link zum Volltext

Verfügbarkeit prüfen

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Journal of Virology, 2012-09, Vol.86 (18), p.10218-10220

2012

Link zum Volltext

Verfügbarkeit prüfen

HIV Entry and Its Inhibition: How Do Chemokines Fit In?

Retrovirology, 2005-12, Vol.2 (S1), p.S7-S7, Article S7

Hartley, Oliver

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Clinical & translational immunology, 2020, Vol.9 (12), p.e1220-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

CCR5: Established paradigms and new frontiers for a ‘celebrity’ chemokine receptor

Cytokine (Philadelphia, Pa.), 2018-09, Vol.109, p.81-93

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(107)
Humans
(89)
Animals
(42)
Biochemistry & Molecular Biology
(29)
Biological And Medical Sciences
(28)
Female
(28)
Human Immunodeficiency Virus
(22)
Immunology
(22)
Medical Sciences
(22)
Molecular Sequence Data
(20)
Receptors, Ccr5 - Metabolism
(20)
Amino Acid Sequence
(19)
Male
(19)
Hiv
(18)
Multidisciplinary Sciences
(18)
Science & Technology - Other Topics
(18)
Physical Sciences
(17)
Chemokine Ccl5 - Pharmacology
(16)
Virology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Recombinant Antibodies for Academia: A Practical Approach

Author Correction: Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Microbicides and other topical strategies to prevent vaginal transmission of HIV

Deciphering the code for retroviral integration target site selection

HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines

Targeting Chemokine Receptors in HIV : A Status Report

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Prevention of Vaginal SHIV Transmission in Rhesus Macaques through Inhibition of CCR5

Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide

Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5

Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants

The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?

Alteration of synaptic network dynamics by the intellectual disability protein PAK3

Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity

An engineered CX3CR1 antagonist endowed with anti-inflammatory activity

Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1

Medicinal Chemistry Applied to a Synthetic Protein: Development of Highly Potent HIV Entry Inhibitors

Efficient Orthogonal Bioconjugation of Dendrimers for Synthesis of Bioactive Nanoparticles

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

HIV Entry and Its Inhibition: How Do Chemokines Fit In?

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

CCR5: Established paradigms and new frontiers for a ‘celebrity’ chemokine receptor

Suchergebnisse filtern